BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 11, 2013
View Archived Issues
Fumarate increased in ER-negative breast cancer in African American women
Read More
BB2 receptor expression elevated in low-grade PIN
Read More
Cancer Research Technology and AstraZeneca extend cancer metabolism alliance
Read More
RXi Pharmaceuticals and OPKO Health pool RNAi assets
Read More
OncoMed begins dosing in phase I trial of anti-Notch 1 antibody in solid tumors
Read More
Otsuka Pharmaceutical patents novel STEP inhibitors
Read More
Patrys reports additional data from phase I/IIa PAT-SM6 study
Read More
Acceleron begins new phase II trial to investigate ACE-536 in beta-thalassemia
Read More
Pernix Therapeutics completes acquisition
Read More
FDA advisory committee votes against salmon calcitonin use
Read More
Lpath and Provista Diagnostics collaborate to develop cancer diagnostics
Read More
CoCo Therapeutics founded to advance research findings in Alzheimer's disease
Read More
Qu Biologics commences phase I/II trial in Crohn's disease
Read More
Protalix gains approval to initiate study of oral treatment for Gaucher's disease in Israel
Read More
NeoStem to proceed with PreSERVE AMI phase II trial following second interim review
Read More
ITX-5061 proves safe, effective and virologically active following oral dosing
Read More
First in-human pharmacokinetic study for DA-0831
Read More
Korean researchers present clinical data for DP-R206 and ibandronate
Read More
HanAll BioPharma patents new AMPK inhibitors
Read More
Nippon Shinyaku patents novel MPGES-1 inhibitors
Read More
Researchers at Boehringer Ingelheim synthesize new sGC activators
Read More
Canadian team discloses new agents for cancer
Read More
Takeda seeks European approval of vedolizumab
Read More
Roche ends fibrosis alliance with Galapagos
Read More
Novel mutations in the ECM1 gene identified in siblings with lipoid proteinosis
Read More
APT imaging is able to differentiate high-grade brain tumors
Read More
Health Canada approves mirabegron
Read More